SDEVStablecoin Development Corp.Healthcare · Medical - Pharmaceuticalsas of 2026-09-04
Horizon

Issued 2026-09-04 at $1.04 · now $0.84 (2026-09-16, −19.6% since)

Based on its own history, a month from the 2026-09-04 close, SDEV has typically landed between $0.69 and $1.50 — a range of −33.9% to +44.4% from the issuance price $1.04.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

105 overlapping 1 month windows · 2026-03-092026-08-06 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-04 issuance close ($1.04) — the price the forecast resolves against on 2026-10-05, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where SDEV has typically landed a month from the 2026-09-04 close of $1.04 — the range is history, not a prediction.

$0.6875worst · -33.9%$1.5best · +44.4%
  • now $0.836 (-19.6%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.02 (-2.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $0.8747$1.16
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $0.6875$1.5
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 112 windows spanning 2026-03-09 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2026-05-13−43.3%−43.3%+0.0%
2026-05-12−37.4%−40.2%+2.3%
2026-05-08−36.2%−36.2%+9.2%
3 best
2026-03-09+40.3%−6.5%+57.3%
2026-03-13+37.2%−4.1%+61.2%
2026-06-05+33.9%−9.8%+33.9%

112 overlapping windows · 2026-03-092026-09-16 · not cherry-picked

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$2$12026-06-15: 3 insider sales, $81K — R01 Fund LP, Framework Ventures IV L.P., Kazley Michael John2026-01-16: 3 insider purchases, $133.8M — R01 Fund LP, Kazley Michael John, Framework Ventures IV L.P.2026-01: 3 open-market purchases, $133.8M2026-06: 3 open-market sales, $81K↑ buys↓ salestenPercentOwner R01 Fund LP — Sale on 2026-06-15, filed 2 days after the tradetenPercentOwner Framework Ventures IV L.P. — Sale on 2026-06-15, filed 2 days after the tradedirector Kazley Michael John — Sale on 2026-06-15, filed 2 days after the tradetenPercentOwner R01 Fund LP — Purchase on 2026-01-16, filed 123 days after the tradedirector Kazley Michael John — Purchase on 2026-01-16, filed 123 days after the tradetenPercentOwner Framework Ventures IV L.P. — Purchase on 2026-01-16, filed 123 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-06-15R01 Fund LPtenPercentOwnerSale24,720 @ $1.09$27K−0.1% of holding+15.1%not yet — horizon still open22,668,516Form 4 · filed 2 days after the trade
2026-06-15Framework Ventures IV L.P.tenPercentOwnerSale24,720 @ $1.09$27K−0.1% of holding+15.1%not yet — horizon still open22,668,516Form 4 · filed 2 days after the trade
2026-06-15Kazley Michael JohndirectorSale24,720 @ $1.09$27K−0.1% of holding+15.1%not yet — horizon still open22,668,516Form 4 · filed 2 days after the trade
2026-01-16R01 Fund LPtenPercentOwnerPurchase53,679,974 @ $0.85$45.6Mownership Δ n/anot yet — horizon still opennot yet — horizon still open53,679,974Form 4 · filed 123 days after the trade
2026-01-16Kazley Michael JohndirectorPurchase53,679,974 @ $0.85$45.6Mownership Δ n/anot yet — horizon still opennot yet — horizon still open53,679,974Form 4 · filed 123 days after the trade
2026-01-16Framework Ventures IV L.P.tenPercentOwnerPurchase50,109,253 @ $0.85$42.6Mownership Δ n/anot yet — horizon still opennot yet — horizon still open50,109,253Form 4 · filed 123 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

12 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-06-15R01 Fund LPtenPercentOwnerExercise11,332,02022,693,236Form 4
2026-06-15Framework Ventures IV L.P.tenPercentOwnerExercise11,332,02022,693,236Form 4
2026-06-15Kazley Michael JohndirectorExercise11,332,02022,693,236Form 4
2026-06-15Framework Ventures IV L.P.tenPercentOwnerExercise11,332,0200Form 4
2026-06-15Kazley Michael JohndirectorExercise11,332,0200Form 4
2026-06-15R01 Fund LPtenPercentOwnerExercise11,332,0200Form 4
2026-03-31Sit SwandirectorAward / grant140,000140,000Form 4
2026-03-31Zheng YenyoudirectorAward / grant140,000140,000Form 4
2026-03-31Kazley Michael JohndirectorAward / grant4,118,8284,118,828Form 4
2026-03-31Kazley Michael JohndirectorAward / grant7,722,8027,722,802Form 4
2026-03-31Freiman Paul E.directorAward / grant140,000140,000Form 4
2026-03-31Law TommyofficerAward / grant300,000300,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.